Noxopharm Ltd V.NOX

Primary Symbol: NOXOF

Healthcare Biotechnology

Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance messenger ribonucleic acid (mRNA) vaccines. It utilizes specialist in-house capabilities and partnerships with researchers to build a pipeline of new proprietary drugs based on two technology platforms: Chroma (oncology) and Sofra (inflammation, autoimmunity, and mRNA vaccine enhancement). Chroma is a technology platform focused on the development of multiple drug candidates, primarily for cancer treatment. The Sofra technology platform has a pipeline of proprietary drugs based on oligonucleotides, the building blocks of deoxyribonucleic acid (DNA), with a focus on mRNA vaccines and the treatment of autoimmune and inflammatory diseases. SOF-VAC has applications in the treatment of excessive inflammatory responses associated with specialized inflammatory receptors in the body known as Toll-like receptor 7.

OTCPK:NOXOF - Post by User

Noxopharm Ltd > 50 cents? A pittance for such valuable assets.

<< Previous

Bullboard Posts

Next >>

Comment by MrMonkon Jan 13, 2016 7:57pm

139 Views

Post# 24456164

RE:RE:RE:50 cents? A pittance for such valuable assets.

Thank you for your feedback. I am trying to add value to this board - I've got better things to do than waste time I don't have. We need to now play the hand we're dealt. I am trying to look at the positives (and there are some).

-- MM

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec